ปัจจัยที่มีความสัมพันธ์กับการเสียชีวิตของผู้ป่วยโรคติดเชื้อไวรัสโคโรนา 2019

Authors

  • sukontip Pattitanung -hospital
  • Anucha Taiwong
  • Monruedee Sanchan

Keywords:

factors associated with mortality, mortality, coronavirus disease 2019 patients

Abstract

Objective : To study the factors associated with the mortality among patients with coronavirus disease 2019.

Method : The study was conducted via retrospective analytic study, where the sample consisted of patients with coronavirus disease 2019 who were admitted to the isolation unit, Mahasarakham Hospital, between January 1st to March 31st, 2022. A total of 161 subjects were selected via systematic randomization. Data were collected through medical records using data record form for factors associated with mortality among patients with coronavirus disease 2019 and subsequently analyzed using descriptive statistics and inferential statistics through Logistic Regression Analysis. Results are reported as adjusted odds ratio (ORadj) and 95% confidence interval.

Result : A majority of patients were female (60.2%), with mean ages of 52.89 ± 20.87 years (range between 15 to 95 years), have at least one underlying disease (49.70%). The factors that played a statistically significant role in the mortality among patients with coronavirus disease 2019 (p < .05) included age of more than 50 years (ORadj= 1.94; 95% CI = 1.89-1.99), have at least one underlying disease (ORadj =5.07; 95% CI = 1.16-22.07), has chronic kidney disease (ORadj= 10.34; 95% CI = 2.25-47.37), and an oxygen saturation level at reception lower than 96% (ORadj= 9.11; 95% CI = 2.44-34.06) and has a history of receiving at least one dose of vaccination (ORadj= 0.065; 95% CI= 0.02-0.20). Furthermore, the study also revealed that immunization was found to be a protective factor (ORadj= 0.065; 95%CI= 0.02-0.20).

Conclusion : There should be awareness and close surveillance among patients with coronavirus disease 2019 who are over 50 years of age and have at least one underlying disease, has chronic kidney disease, and an oxygen saturation level at reception lower than 96% in order to reduce the mortality in this group of patients.

References

Jackson JK. Global economic effects of COVID-19. Congressional Research Service; 2021.

Feinhandler I, Cilento B, Beauvais B, Harrop J, Fulton L, editors. Predictors of death rate during the COVID-19 pandemic. Healthcare. 2020;8(3):1-16

Grant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS- CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries.PloS one. 2020;15(6):1-19.

Banchongcharoenlert S, Chumchuen P. Case fatal rate and factors associated with deaths due to COVID-19 in Damnoen Saduak Hospital, Ratchaburi province. Journal of Research for Health Improvement and Quality of Life. 2022;2(1):25-37.

Patipanwat P. Factors of affecting fatality with COVID-19 patients in Kalasin hospital. Journal of Health and Environmental Eucation. 2022;7(1):64-71.

Bujang MA, Sa’at N, Bakar TMITA, Joo LC. Sample size guidelines for logistic regression from observational studies with large population: emphasis on the accuracy between statistics and parameters based on real life clinical data. The Malaysian Journal of Medical Sciences. 2018;25(4):122-38.

Polit DF, Beck CT, Owen SV. Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Research in Nursing Health. 2007;30(4):459-67.

Boe D, Boule L, Kovacs E. Innate immune responses in the ageing lung. Clinical Experimental Immunology. 2017;187(1):16-25.

Wu Z, McGoogan J. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42.

Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, et al. Geroscience: linking aging to chronic disease. Cell. 2014;159(4):709-13.

Prakash S, O'Hare AM, editors. Interaction of aging and chronic kidney disease. Seminars in nephrology; 2009: Elsevier.

Syed-Ahmed M, Narayanan M. Immune dysfunction and risk of infection in chronic kidney disease. Advances in chronic kidney disease. 2019;26(1):8-15.

Bhaskaran K, Bacon S, Evans SJ, Bates CJ, Rentsch CT, MacKenna B, et al. Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. The Lancet Regional Health-Europe. 2021;6:1-10.

Koirala A, Joo YJ, Khatami A, Chiu C, Britton PN. Vaccines for COVID-19: The current state of play. Paediatric respiratory reviews. 2020;35:43-9.

Mohammed I, Nauman A, Paul P, Ganesan S, Chen K-H, Jalil SMS, et al. The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review. Human vaccines immunotherapeutics. 2022;18(1):2027160-20.

Downloads

Published

2022-12-27

How to Cite

Pattitanung, sukontip, Taiwong, A. ., & Sanchan, M. . (2022). ปัจจัยที่มีความสัมพันธ์กับการเสียชีวิตของผู้ป่วยโรคติดเชื้อไวรัสโคโรนา 2019. Mahasarakham Hospital Journal, 19(3), 197–206. retrieved from https://he02.tci-thaijo.org/index.php/MKHJ/article/view/259474